Indian clopidogrel market in January 2026 softened as sellers responded to muted buying after year-end stock-building. Early-month spot demand eased as domestic formulators trimmed call-offs and deferred routine purchases into February tender rounds, while fourth-quarter institutional buying had largely concluded. Production ran near normal through mid-month, and plant-gate inventories remained above seasonal norms, prompting producers to offer concessions to shift volumes by month-end. The overall tone was cautious rebalancing: steady export enquiries cushioned producers but did not generate fresh demand sufficient to offset softer domestic procurement and distributor destocking. Demand varied by channel: domestic formulators reduced finished-dosage antiplatelet call-offs, whereas the broader antithrombotic finished-dosage market retains structural strength with a notable long-term growth trajectory supporting volumes. Public procurement via the Jan Aushadhi scheme remained important but monthly off-take slowed after heavy Q4 purchases. Export bulk API orders to major markets held steady, cushioning producers. Outlook points to headwinds before normalization, with prices projected to ease later.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
